Wolverine Asset Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Wolverine Asset Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-500	Closed	-$86K	–	1701
2019 Q2	$86K	Sell	500 -1,800	-78%	-$311K	﹤0.01%	1150
2019 Q1	$387K	Sell	2,300 -87,800	-97%	-$13.1M	0.01%	919
2018 Q4	$8.77M	Buy	+90,100	New	+$11.8M	0.11%	176

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $983M AUM 34.23% 1-Year Est. Return

Wolverine Asset Management's GWPH Position: Q2 2021 in Review

Wolverine Asset Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 14,567 shares — an estimated $3.16M sold.

Wolverine Asset Management first reported a position in GWPH in Q1 2019 and held it in 4 quarters. The position peaked at $3.16M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Wolverine Asset Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Wolverine Asset Management sold 14,567 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $3.16M.
Wolverine Asset Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2019 and held it in 4 quarters.
Wolverine Asset Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $3.16M in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Wolverine Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.